Home > News > Nucryst Looks to Zap Zits
March 10th, 2006
Nucryst Looks to Zap Zits
Jack Uldrich: Yesterday, Nucryst announced that it had been granted a new patent that covers the company’s poprietary nanocrystalline silver for treating acne.
Given the number of teenagers that still suffer from this vexing condition, the patent could prove to be very profitable for the company. In my estimation, however, this news alone is not enough to change my bearish opinion of Nucryst.
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014
Harris & Harris Group Invests in Unique NYC Biotech Accelerator July 29th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014
Nanometrics Announces Upcoming Investor Events July 22nd, 2014